Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Shares Up 1.9% – Should You Buy?

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)’s stock price rose 1.9% during mid-day trading on Wednesday . The stock traded as high as $39.57 and last traded at $39.40. Approximately 7,334 shares traded hands during mid-day trading, an increase of 32% from the average daily volume of 5,572 shares. The stock had previously closed at $38.65.

Innovator IBD Breakout Opportunities ETF Price Performance

The business has a 50-day simple moving average of $37.14 and a two-hundred day simple moving average of $37.67. The stock has a market cap of $13.79 million, a price-to-earnings ratio of 28.69 and a beta of 1.08.

Innovator IBD Breakout Opportunities ETF Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Friday, January 2nd. Investors of record on Wednesday, December 31st were issued a dividend of $0.1249 per share. The ex-dividend date of this dividend was Wednesday, December 31st. This represents a dividend yield of 34.0%.

Hedge Funds Weigh In On Innovator IBD Breakout Opportunities ETF

Several institutional investors and hedge funds have recently modified their holdings of the stock. Osaic Holdings Inc. raised its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the period. Comprehensive Wealth Management LLC grew its stake in Innovator IBD Breakout Opportunities ETF by 60.5% in the 3rd quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after buying an additional 3,976 shares during the last quarter. Finally, Susquehanna International Group LLP raised its holdings in Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after acquiring an additional 7,817 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.